Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
RITUXIMAB | Treatment noncompliance | 1 |
RITUXIMAB | Tumour haemorrhage | 1 |
Rituximab | Type 2 diabetes mellitus | 1 |
RITUXIMAB | Ulcer | 1 |
Rituximab | Umbilical hernia, obstructive | 1 |
RITUXIMAB | Unevaluable event | 1 |
Rituximab | Upper respiratory tract inflammation | 1 |
Rituximab | Urethral caruncle | 1 |
Rituximab | Vaccination failure | 1 |
rituximab | Vena cava thrombosis | 1 |
Rituximab | Ventricular fibrillation | 1 |
RITUXIMAB | Ventricular tachycardia | 1 |
Rituximab | Vertigo | 1 |
Rituximab | Viral myocarditis | 1 |
RITUXIMAB | Visceral leishmaniasis | 1 |
RITUXIMAB | Visual impairment | 1 |
RITUXIMAB | Vitamin B12 deficiency | 1 |
RITUXIMAB | Vocal cord atrophy | 1 |
Rituximab | Weight fluctuation | 1 |
RITUXIMAB | Weight increased | 1 |
Total Records: 1,104 Number of Pages: 56